Amelioration of Sepsis by TIE2 Activation- Induced Vascular Protection. Jenn Hou Burke Group Literature Seminar June 18 th 2016

Similar documents
Writing Effective Grant Proposals

Preventing malaria-associated death and disability Why outcomes matters. Kevin Kain MD Director, Tropical Disease Unit University of Toronto

Intravenous Vitamin C. Severe Sepsis Acute Lung Injury

BIOMARKERS IN SEPSIS: DO THEY REALLY GUIDE US? Asist. Prof. M.D. Mehmet Akif KARAMERCAN Gazi University School of Medicine Depertment of Emergency

The Angiopoietin Axis in Cancer

Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation

Gene expression profiling in pediatric septic shock: biomarker and therapeutic target discovery

The Importance of Glutamine and Antioxidant Vitamin Supplementation in HIV

Basis of Immunology and

IL-24 AND ITS ROLE IN WOUND HEALING

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

Cytomegalovirus in critically ill patients

Nature Immunology doi: /ni.3268

ESPEN Congress Prague 2007

Sepsi: nuove definizioni, approccio diagnostico e terapia

2. Innate immunity 2013

SHOULD THERAPEUTIC AGENTS FOR SEPSIS TARGET THE GLYCOCALYX?

Supplementary Figures for TSC1 controls macrophage polarization to prevent inflammatory disorder by Linnan Zhu et al

Angiostasis and Angiogenesis Regulated by Angiopoietin1-Tie2 Receptor System

Bacteriemia and sepsis

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS

Cloudbreak. January Cidara Therapeutics

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,

Endothelial PGC 1 - α 1 mediates vascular dysfunction in diabetes

Use of the Free Electron Laser for the Noninvasive Determination of Retinal Oxyhemoglobin Saturation by Near Infrared Reflectance Spectrophotometry

CONTRACTING ORGANIZATION: Rush University Medical Center Chicago, IL 60612

Support Funding for the Military Burn Research Program in FY19

Immunobiotics: Cloudbreak Antibody Drug Conjugates (ADC) Les Tari, PhD VP Discovery

Immunological biomarkers predictive of clinical response to chemotherapy and maintenance HAART in HIV + patients with Kaposi sarcoma

Journal of Infectious Diseases Advance Access published August 25, A Practical Treatment for Patients with Ebola Virus Disease

Mechanisms of Resistance to Antiangiogenic. Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center Dresden, 2012

Toll-like Receptor Signaling

Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany

TREATMENT STRATEGIES FOR THE ENDOTHELIOPATHY OF TRAUMA

A Central Role of MG53 in Metabolic Syndrome. and Type-2 Diabetes

Cloudbreak. March Cidara Therapeutics

Innate Immunity. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples Chapter 3. Antimicrobial peptide psoriasin

Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD

Tissue repair. (3&4 of 4)

Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium. fortunei via suppression of MMP-9 activity and VEGF production

TOLL-LIKE RECEPTORS AND CYTOKINES IN SEPSIS

Early cell death (FGF) B No RunX transcription factor produced Yes No differentiation

a. b. c. d. e. f. g. h. i. j. k. l. m. n. o. p.

VWF other roles than hemostasis. Summary 1: VWF & hemostasis synthesis 11/4/16. Structure/function relationship & functions kDa.

Signaling Vascular Morphogenesis and Maintenance

Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts

Neue Wirkungsmechanismen von Transfusionsplasma

Cell-Derived Inflammatory Mediators

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

Approach to disseminated intravascular coagulation

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.

BIOMARKERS IN SEPSIS

Supplementary Figure 1. Basal level EGFR across a panel of ESCC lines. Immunoblots demonstrate the expression of phosphorylated and total EGFR as

Regulation of the Cell Cycle CHAPTER 12

INFLAMMATION & REPAIR

Blood is serious business

Towards Precision Medicine in Sepsis Patients: Are We Close?

CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK: CISS Phase I Trial

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Supplemental Figure 1. (A) Western blot for the expression of RIPK1 in HK-2 cells treated with or without LPS (1 µg/ml) for indicated times.

Follicular Lymphoma. ced3 APOPTOSIS. *In the nematode Caenorhabditis elegans 131 of the organism's 1031 cells die during development.

SEPTIC ARTHRITIS. Dr Ahmed Husam Al Ahmed Rheumatologist SYRIA. University of Science and technology Hospital Sanaa Yemen 18/Dec/2014

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

MALIGNANT CACHEXIA (CACHEXIA ANOREXIA SYNDROME): Overview

Subclinical inflammation and peripheral artery disease. Luigi M Biasucci, M.D. Institute of Cardiology Catholic University Rome, ITALY

Bacterial translocation in cirrhosis

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Reviewing biomedical role of Plasma Gelsolin

Part-I: Screening. 3.1 Assessment of non-toxic concentration of test compounds in RAW cells. Results

Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation

Monitoring Tumor Therapy

Bacteriology -1- Bacteremia

Effects of fentanyl, midazolam and their combination on immune function and mortality in mice with sepsis

The TNF & TNF receptor superfamillies

Supplementary information to: Mechanism of lipopolysaccharide-induced skin edema formation in the mouse

Intracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation

Bench to Bedside PCSK9 Children are Different

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Pathophysiology of Catheter-Related Infection. All sources of infection are potential targets for prevention. Infusates/ drugs. hub/lines Dressing

Sepsis and Multiple Organ Failure. J.G. van der Hoeven Radboud University Nijmegen Medical Centre

Sepsis and Infective Endocarditis

Cell Death & Renewal (part 2)

Targeting angiogenesis in cancer

Immunocompromised patients. Immunocompromised patients. Immunocompromised patients

How the Innate Immune System Profiles Pathogens

Thomas HAIDER Journal Club

Increasing barrier function with multispecies probiotics

Immunology lecture: 14. Cytokines: Main source: Fibroblast, but actually it can be produced by other types of cells

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye

Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment

Disseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.

Sepsis and Shock States

Pathologic Mechanisms of Septic Shock

Interference of the general anesthetics propofol and isoflurane on lung morphology in mice septic

THE PHYSIOLOGICAL IMPACT OF TRAUMA AND INFECTION = The Metabolic Response to Stress

Research Development: Bedside to Bench and Back

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction

Page 39 of 44. 8h LTA & AT h PepG & AT h LTA

Typhoidal pathogens. - S. Typhi Vi-positive - S. Typhi Vi-negative. Journal of clinical microbiology, 2005,

Transcription:

Amelioration of Sepsis by TIE2 Activation- Induced Vascular Protection Jenn Hou Burke Group Literature Seminar June 18 th 2016

Sepsis Globally, more than 19 million people are affected each year Causes mortality in half of sepsis patients Unregulated immune response to bacterial and viral infections Hallmarks: massive inflammation, blood vessel dilation, vascular leakage, multipleorgan failure (heart, kidney, lungs and/or liver) Risk Factors: Immuno-compromised (age, chemotherapy, HIV) ICU hospitalization Bodily injury and wounds Catheterization Image from: https://my.vanderbilt.edu/sepsismonitor/files/2013/10/sirs.jpg Image from: http://www.westvalleytrauma.com/2015/03/sepsis-in-the-trauma-patient/ https://www.nlm.nih.gov/medlineplus/sepsis.html http://global-sepsis-alliance.org/global-burden/ http://www.mayoclinic.org/diseases-conditions/sepsis/symptoms-causes/dxc-20169787

The Pathophysiology of Sepsis Parikh SM (2016) Targeting Tie2 and the host vascular response in sepsis. Science Translational Medicine. 8(335): 1-3. Brindle NPJ, Saharinen P, Alitalo K (2006) Signaling and functions of angiopoitein-1 in vascular protection. Circulation Research. 98: 1014-1023.

ANG2-Binding and TIE2-Activating Antibody (ABTAA) Associates with ANG2 to Promote TIE2 Activation Can ABTAA bind to ANG2 to trigger TIE2 phosphorylation in cells? K D =0.2nM K D =78pM Confluent, serum starved HUVEC ABTAA binding to ANG2 promotes TIE2 activation and cell-cell localization in vitro.

ABTAA + ANG2 Promote Downstream TIE2 Signaling How does ABTAA + ANG2 binding affect cell signaling? Confluent, serum starved HUVEC

TIE2 Knockdown Abrogates ABTAA Mediated AKT and ERK Phosphorylation How does the loss of function of TIE2 affect AKT and ERK signaling? TIE2 function is critical for downstream signaling.

ABTAA Complexes with ANG2 and TIE2 Is ANG2 required for ABTAA and TIE2 interactions? Size Exclusion Chromatography A2D: ANG2 s fibrinogen-like domain T2E: TIE2 s extracellular domain A2D and T2E associate 1:1 Non-Reducing SDS-PAGE Multi-Angle Light Scattering Enzyme Linked Immunosorbent Assay

ABTAA Promotes ANG2 Oligomerization Hypothesis: ABTAA can interact with multiple ANG2 to enhance its oligomerization. 1330 kd 998 kd 677 kd

How Does ABTAA Affect Survival in a Murine Sepsis Model? High-Grade Cecal Ligation and Puncture (CLP) Hypothesis: ABTAA will improve the survival of septic mice compared to ABA. Treat mice with Fc, ABA, or ABTAA 6 to 18 hours post-clp. Track progress of mice in blind study. Image from: http://www.nature.com/nrd/journal/v4/n10/images/nrd1854-f3.jpg Image from: http://faculty.ccbcmd.edu/courses/bio141/lecguide/unit5/innate/u1fig26l1.html Image from: https://en.wikipedia.org/wiki/large_intestine#/media/file:blausen_0604_largeintestine2.png

ABTAA Improves the Survival of Septic Mice Post-CLP ABTAA: 40% survival ABA: 13% survival How does co-administration of ABTAA and broad spectrum antibiotics impact survival outcomes? Imipenem: 20% survival ABTAA + Imipenem: 70% survival

Pre-Administration of ABTAA Prior to CLP Provides Protective Effects in Mice Does pretreatment with ABTAA improve survival in septic mice? ABTAA pre-treat: 50% survival ABA pre-treat: 17% survival Higher doses of ABA does not improve septic mouse survival.

ABTAA Rescues Mice from Endotoxemia and Bacteremia How general is the protective effect of ABTAA against two alternative mouse models of sepsis? Structure of Lipopolysaccharide ABTAA: 63% survival ABA: 33% survival Fc: 28% survival ABTAA: 55% survival ABA: 9% survival Fc: 8% survival Image from: https://www.researchgate.net/figure/233962820_fig1_figure-1-lipopolysaccharide-lps-a-schematic-diagram-of-the-structure-of-lps-b

How Does Loss of Function of ABTAA s Binding Partners Affect Its Efficacy Against Sepsis? Loss of ANG1 accelerates death. ANG2 antagonizes TIE2. ABTAA association with TIE2 is required for survival.

ABTAA Protects Against Acute Lung Injury by Decreasing Leakage Experimental Set-Up

ABTAA Protects Against Acute Lung Injury by Maintaining Pericyte Coverage CLP was performed, and mice were treated 6 and 18 hours afterwards. Pericyte coverage = NG2 area /CD31 area ABTAA activates TIE2 to prevent EC-pericyte dissociation. Bergers G, Song S. (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro. Oncol. 7(4): 452-464. Huang H et al. (2010) Targeting the ANGPT-TIE2 pathway in malignancy. Nature Reviews Cancer. 10: 575-585.

ABTAA Protects Against Sepsis by Retaining Endothelial Glycocalyx Integrity Thickness of Subpleural Microvasculature Endothelial surface layer

ABTAA Protects Against Sepsis by Retaining Endothelial Glycocalyx Integrity ABTAA reduces the expression of heparanase to maintain blood vessel wall integrity.

ABTAA Protects Against TNF-α Mediated Vascular Leakage

ABTAA Reduces Proinflammatory Cytokine and ANG2 Levels Damas P et al. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 215(4): 356-362.

Proposed Model of ABTAA Mediated Amelioration of Sepsis

Conclusions ABTAA binds to ANG2 to activate TIE2 receptors and trigger downstream phosphorylation. ABTAA rescues mice in three separate sepsis models. Co-administration of ABTAA with antibiotics further improves septic mouse survival. ABTAA alleviates septic severity by protecting against vascular leakage, reducing lung edema, maintaining glycocalyx integrity, and decreasing proinflammatory signals. ABTAA could act as a viable new therapeutic candidate for the prophylaxis of and treatment of sepsis.